Multi-Omics Insights into the Impact of MDH2 on Breast Cancer Progression: A Promising Druggable Target
Our findings highlight the role of MDH2 in breast cancer metabolism and suggest it as a promising target for cancer therapies targeting metabolism and tumor growth.
Authors
- Zhongguang Luo (ORCID: https://orcid.org/0000-0002-7620-307X)
- Zhimin Yang (ORCID: https://orcid.org/0009-0009-7549-3456)
- Chenglai Xia (ORCID: https://orcid.org/0000-0002-4528-7960)
- Botao Pan (ORCID: https://orcid.org/0000-0002-9678-1512)
- Xiujuan Yang
- Qingqing Liu (ORCID: https://orcid.org/0009-0000-9751-518X)
Institutions
- Southern Medical University (CN)
Publication Details
- Journal
- Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.32604/or.2025.068119
- Citations
- 1
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.94